MedChemComm

MedChemComm (in full: Medicinal Chemistry Communications) is a peer-reviewed scientific journal publishing original (primary) research and review articles on all aspects of medicinal chemistry, including drug discovery, pharmacology and pharmaceutical chemistry. It is published monthly by the Royal Society of Chemistry in partnership with the European Federation for Medicinal Chemistry, of which it is the official journal. Authors can elect to have accepted articles published as open access.[1] According to the Journal Citation Reports, the journal has a 2014 impact factor of 2.495, ranking it 27th out of 59 journals in the category "Chemistry, Medicinal"[2] and 163 out of 289 journals in the category "Biochemistry & Molecular Biology".[3]

MedChemComm
DisciplineChemistry, medicine
LanguageEnglish
Edited byGerhard Ecker
Publication details
History2010-present
Publisher
Royal Society of Chemistry (United Kingdom)
FrequencyMonthly
Hybrid
2.495 (2014)
Standard abbreviations
ISO 4MedChemComm
Indexing
ISSN2040-2503 (print)
2040-2511 (web)
LCCN2011243017
OCLC no.663378788
Links

The editor-in-chief is Gerhard Ecker (University of Vienna, Austria).[4]

Article types

MedChemComm publishes Research Articles (original scientific work, usually between 4-10 pages in length) and Reviews (critical analyses of specialist areas).[4]

References

  1. "RSC Open Science". Royal Society of Chemistry. 2006-10-01. Retrieved 2012-07-07.
  2. "Journals Ranked by Impact: Chemistry, Medicinal". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015. (subscription required)
  3. "Journals Ranked by Impact: Biochemistry & Molecular Biology". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015. (subscription required)
  4. "About MedChemComm". Royal Society of Chemistry. Retrieved 2018-12-14.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.